Diabetic foot ulcers is a type of chronic wound affecting millions of patients across the globe. Diabetic foot ulcers are thickened wounds below the ankle in a diabetic patient irrespective of its duration. On account of high prevalence of diabetes, increasing geriatric population and lack of awareness on preventive measures the global diabetic foot ulcers market shows a lucrative growth between the forecast period 2023 and 2030.

The current report of diabetic foot ulcers treatment market encompasses offers essential market insights and analysis coupled with it market size, pipeline analysis and forecast estimations for the time scale, 2020-2030. This study covers a complete anatomization of the current market and provides current trends and goals of the existing market leaders.

Market share analysis and forecast estimations for the aforementioned segments are provided in terms of US$ Mn for the forecast period, 2023-2030. Furthermore, the respective growth rates for each segment has also been included. These values have been estimated keeping 2021 as its base year.

The factors that affect the growth of the diabetic foot ulcer treatment market such as market drivers, various opportunities existing within the market and market restraints have been incorporated in this study report. Company partnerships, withdrawals and pipeline molecules with target based therapy to treat diabetic foot ulcers are also one of the key inclusions of this report. The key industries holding dominance in the diabetic foot ulcers market have been identified and profiled in terms of their annual sales and growth, current market trends, key products in diabetic foot ulcer treatments, worldwide presence and generic company details. The key players of this market that have been profiled are Coloplast A/S, Medtro nic Plc., Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries, Inc., BSN Medical GMBH, Molnlycke Health Care AB, Acelity L.P. Inc., Organogenesis, Inc., 3M Healthcare, Smith & Nephew Plc., ConvaTec, Inc., Oneness Biotech Co., Ltd., Dipexium Pharmaceuticals, Inc., ViroMed Co., Ltd. & FirstString Research, Inc. A competitive landscape of the aforementioned players pertaining to their market dominance has also been presented in this report.

The diabetic foot ulcers can be characterized as neuropathic, ischemic or neuro-ischemic ulcers, depending on the etiology of the ulcer and complexity.  Among the mentioned type, neuropathic ulceration remains the most common type of ulcer. However there has been massive increase in prevalence of neuro-ischemic ulcers in the recent years, accounting for 50% of the foot ulcer in 2013 as per International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Neuro-ischemic ulcers show presence of neuropathic symptoms along with gangrene wherein the onset is sudden with pain and discoloration. Owing to an advancement in diagnostic tools, development of target based medications and an extensive treatment approach in order to prevent the occurrence of gangrene, the neuro-ischemic ulcers is projected to encapsulate a larger market share in the diabetes foot ulcer treatment market in the forecast period, 2023-2030.

The preliminary goal of diabetic foot ulcer treatment is to acquire wound closure. The treatment and management of foot ulcers is solely based on the extent of severity of the ulcer and presence of infection. A multidisciplinary treatment approach is adopted thus reducing the need for amputation. The available treatment options comprises wound care dressings, bio-actives, wound care devices and antibiotic medications; bio-actives grab a larger share of the diabetic foot ulcer treatment market. Bio-actives are further segmented into growth factors, skin grafts and others. Growth- factors are globally prescribed for the treatment of diabetic foot ulcers as it promotes growth of new cells and attains wound closure, preventing the risk of infections. The increase in prevalence of diabetic foot ulcers has fueled the demand for treatment by growth-factors. Wound care dressings and wound care devices line up second in this segment due to easy availability of these treatment options, cost-effective benefits and its preliminary use for every level of severity of wound care management combined with other treatment options.

The global diabetic foot ulcers treatment market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Of the aforementioned segments, North America accounts for major share in the diabetic foot ulcers market due to increasing prevalence of diabetes, rising geriatric population, emphasis of development of break through molecules and developed healthcare infrastructure. The Medicare program in the U.S. spends more than US$ 9 billion annually on patients with diabetes-associated lower-extremity wounds, denoting availability of reimbursement policies propelling the growth of this market. Europe lines up second in this market after North America. As per The National Institute for Health and Care Excellence (NICE) the annual cost for treating diabetic foot wounds accounts to £650 million. The rise in prevalence of diabetes, developed healthcare infrastructure and availability reimbursement policies have fueled the European diabetic foot ulcers treatment market. Asia Pacific is expected to grow at a faster rate in this market in during the forecast period of 2023-2030. This growth is attributed to factors such as increasing prevalence of diabetes, development of better healthcare infrastructure and continuous efforts to maintain sustainable healthcare growth by financial inclusions.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetic Foot Ulcers Treatment market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Diabetic Foot Ulcers Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Diabetic Foot Ulcers Treatment market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Diabetic Foot Ulcers Treatment market?
• Which is the largest regional market for Diabetic Foot Ulcers Treatment market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Diabetic Foot Ulcers Treatment market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetic Foot Ulcers Treatment market worldwide?